BioCentury | Mar 3, 2011
Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Cancer CD70 (CD27L) Studies in mice and in cell culture suggest that CD70-targeted T cell immunotherapy could help treat CD70+...
BioCentury | May 27, 2010
Targets & Mechanisms

Coaxing cancer to defect

...The specific factors targeted in those studies were SMG1 homolog phosphatidylinositol 3-kinase related kinase ( SMG1...
...cells transduced with a lentiviral vector expressing small hairpin RNAs that targeted the NMD factors Smg1...
...the technique could treat existing tumors. Gilboa and colleagues conjugated small interfering RNA against either Smg1...
BioCentury | Jun 7, 1999
Company News

Quintiles, Minerva Medical plc, SMG Marketing Group Inc. deal

QTRN acquired Minerva, a CRO, in a pooling-of-interests stock transaction. Minerva will operate under its own name as a specialty business unit of QTRN's Quintiles Product Development group. Separately, QTRN acquired SMG, a healthcare market...
Items per page:
1 - 3 of 3